Literature DB >> 2784289

Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens.

S Sirko1, I Bishai, F Coceani.   

Abstract

Conscious cats were used to study the local release of prostaglandin (PG) E2 and thromboxane (Tx) B2 (the stable TxA2 by-product) from the preoptic-anterior hypothalamus (AH-POA) and the tuberal-posterior hypothalamus (PH-Tu) using a modified "push-pull" perfusion procedure. In the absence of fever, PGE2 release was steady from the 2nd h of perfusion onward, its rate at either site ranging between 0.08 and 0.12 pg/min. Local treatment with probenecid (1 mM) increased PGE2 release about threefold. Compared with PGE2, basal release of TxB2 was greater (0.15-0.43 pg/min) and, occasionally, tended to fall with time. Both compounds were found in higher amounts (2- to 10-fold increase) after locally injecting endotoxin, and the effect was greater in AH-POA than PH-Tu. Conversely, intravenous endotoxin (bolus) or interleukin 1 (IL-1) (bolus plus infusion) at doses causing a sustained fever selectively stimulated the formation of PGE2, but the response itself did not differ between AH-POA and PH-Tu. In either region, the degree of enhancement in PGE2 release correlated with the magnitude of the fever. Intravenous indomethacin (2 mg/kg) reversed both the fever and PGE2 elevation. These findings support an intermediary role for PGE2 in the central action of pyrogens and the ensuing fever. Blood-borne pyrogens may act at multiple sites in brain, which are tentatively identified with the circumventricular organs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784289     DOI: 10.1152/ajpregu.1989.256.3.R616

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats.

Authors:  Murat Yalcin; Sinan Cavun; M Sertac Yilmaz; Vahide Savci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

2.  Lack of pyrogenic tolerance transmission between brain and periphery in the rabbit.

Authors:  W Kozak; D Soszynski; M Szewczenko; M Bodurka
Journal:  Experientia       Date:  1990-10-15

3.  Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice.

Authors:  W A Banks; A J Kastin; C A Ehrensing
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

4.  The investigation of possible roles of central 5-HT7 receptors in antipyretic effect mechanism of paracetamol in LPS-induced hyperthermia model of mice.

Authors:  Duygu Kose; Elif Cadirci; Zekai Halici; Busra Sirin; Busra Dincer
Journal:  Inflammopharmacology       Date:  2019-07-15       Impact factor: 4.473

5.  Interleukin-1 receptor antagonist does not prevent endotoxin-induced inhibition of gastric acid secretion in rats.

Authors:  E Saperas; Y Taché
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

6.  A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system.

Authors:  C R Pace-Asciak; O Laneuville; W G Su; E J Corey; N Gurevich; P Wu; P L Carlen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Ciliary neurotrophic factor is an endogenous pyrogen.

Authors:  L Shapiro; X X Zhang; R G Rupp; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Induction of aromatic L-amino acid decarboxylase mRNA by interleukin-1 beta and prostaglandin E2 in PC12 cells.

Authors:  X M Li; A V Juorio; A A Boulton
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

Review 9.  Neuromodulative actions of cytokines.

Authors:  C M Blatteis
Journal:  Yale J Biol Med       Date:  1990 Mar-Apr

10.  The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.

Authors:  G S Smith; C Rieckenberg; W E Longo; D L Kaminski; J E Mazuski; Y Deshpande; T A Miller
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.